Scientists at UCLA Jonsson Comprehensive Cancer Center have identified potential new biomarkers that could indicate response to immunotherapy in people diagnosed with metastatic melanoma.   The researchers found that when T cells are activated, they release a protein called CXCL13 that helps attract more B and T cells to the tumor site. The B cells then present specific parts of the tumor...